Abstract
INTRODUCTION:Rifaximin use in combination with lactulose is associated with a decreased risk of overt hepatic encephalopathy (HE).METHODS:We prospectively evaluated the impact of an interruptive electronic medical record alert to indicate rifaximin for patients with cirrhosis and HE on lactulose.RESULTS:The intervention was associated increased rifaximin utilization, particularly for nongastroenterology and hospitalist services odds ratio 1.20 95% confidence interval (1.09-1.31). For patients with HE, the intervention was associated with a lower readmission risk-adjusted subdistribution hazard ratio 0.63 95% confidence interval (0.48-0.82).DISCUSSION:An interruptive alert in the electronic ordering system was associated with a lower risk of readmissions.
Original language | English (US) |
---|---|
Pages (from-to) | 491-494 |
Number of pages | 4 |
Journal | American Journal of Gastroenterology |
Volume | 117 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1 2022 |
Externally published | Yes |
ASJC Scopus subject areas
- Hepatology
- Gastroenterology